OR10D4P is a G protein-coupled receptor encoded by the OR10D4P gene, classified under olfactory receptor family 10. This seven-transmembrane domain protein localizes to the cell membrane and mediates chemosensory responses to odorants . The OR10D4P antibody is a rabbit-derived polyclonal IgG that detects endogenous OR10D4P expression in human, rat, and mouse tissues .
Cellular Localization: Cell membrane (multi-pass transmembrane protein)
Function: Binds odorant molecules, initiating olfactory signaling cascades .
| Application | Dilution Range | Reactivity |
|---|---|---|
| Western Blot (WB) | 1:500 – 1:2,000 | Human, Rat, Mouse |
| Immunofluorescence (IF) | 1:200 – 1:1,000 | Human |
| ELISA | 1:10,000 | Human |
The antibody demonstrates high specificity for OR10D4P, with no cross-reactivity reported against unrelated proteins .
In WB, it detects a band at the expected molecular weight (~35 kDa) in human olfactory epithelium lysates .
HGNC: 14770
OR10D4P functions as an odorant receptor in the olfactory system . Despite being classified as a pseudogene, research indicates it may still play biological roles worth investigating. The protein is part of the G protein-coupled receptor family that helps convert chemical stimuli into sensory perception. Studying this receptor contributes to our understanding of olfactory signal transduction pathways and potentially sensory disorders involving smell perception.
OR10D4P antibodies have been validated for several experimental applications including Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), and ELISA . Western blotting is particularly effective for quantitative analysis with recommended dilutions of 1:500-1:1000 . For cellular localization studies, immunofluorescence at dilutions of 1:100-1:500 provides optimal results . ELISA applications typically require higher dilutions (1:10000) for specific detection .
Published validation data demonstrates successful detection of OR10D4P in COLO cells and LOVO cells . When planning experiments, these cell lines represent positive controls for antibody validation. Additional cell lines may express OR10D4P, but experimental validation would be necessary before proceeding with full-scale studies.
For rigorous experimental design, multiple controls are essential. Negative controls should include:
Omission of primary antibody
Blocking with immunizing peptide (peptide competition assay) as demonstrated in validation studies
Non-expressing cell lines if available
Positive controls should include:
Known OR10D4P-expressing cells (COLO or LOVO cells)
Recombinant OR10D4P protein if available
Additionally, isotype controls using generic rabbit IgG antibodies help confirm specificity of signal detection .
For OR10D4P immunofluorescence studies, the choice of fixation method significantly impacts epitope accessibility. While the search results don't specify exact fixation protocols, standard approaches for membrane proteins like OR10D4P typically include:
Paraformaldehyde fixation (4%) for 10-15 minutes at room temperature
Mild permeabilization with 0.1-0.2% Triton X-100 or 0.05% saponin
Blocking with 5% normal serum from the same species as the secondary antibody
Optimization of these conditions may be necessary depending on specific cell types and experimental requirements.
Validation of OR10D4P antibody specificity requires multiple approaches:
Peptide competition assay: Pre-incubate antibody with immunizing peptide before application to demonstrate signal reduction or elimination
Western blot analysis: Confirm detection of a single band at the expected molecular weight (~33kDa)
Genetic validation: Compare signal between wildtype cells and those with OR10D4P knockdown/knockout
Cross-reactivity testing: Examine potential cross-reactivity with other olfactory receptors, particularly those with high sequence homology
OR10D4P antibodies should be stored at -20°C for long-term stability . The antibodies are typically provided in a stabilizing buffer containing glycerol (50%), which prevents freeze-thaw damage. To maintain antibody integrity:
Aliquot upon first thaw to minimize freeze-thaw cycles
For short-term use (less than one week), storage at 4°C is acceptable
Avoid repeated freeze-thaw cycles as this significantly reduces antibody activity
When troubleshooting OR10D4P antibody performance in Western blotting:
Increase antibody concentration (try 1:250 if 1:500 shows weak signal)
Extend primary antibody incubation (overnight at 4°C)
Optimize protein loading (30-50μg total protein recommended)
Enhance epitope accessibility:
Ensure complete protein denaturation
Try different membrane types (PVDF vs. nitrocellulose)
Improve transfer efficiency for this membrane protein:
Use lower percentage gels (10-12%) for better transfer
Extend transfer time or optimize transfer buffer composition
Enhance detection sensitivity using more sensitive substrates (chemiluminescent vs. colorimetric)
For optimal signal-to-noise ratio in OR10D4P immunofluorescence:
Use 5% BSA or 5-10% normal goat serum in PBS or TBS
Block for 1 hour at room temperature or overnight at 4°C
Include 0.1-0.3% Triton X-100 in blocking solution for membrane permeabilization
Consider adding 0.05% Tween-20 to washing buffers to reduce non-specific binding
For particularly high background, add 0.1-0.3M NaCl to washing buffers
For co-localization studies examining OR10D4P interactions with other signaling proteins:
Select compatible primary antibodies from different host species (e.g., rabbit anti-OR10D4P with mouse anti-Gαolf)
Use fluorophore-conjugated secondary antibodies with minimal spectral overlap
Include appropriate controls:
Single-labeled samples to assess bleed-through
Secondary-only controls for each fluorophore
Acquire images sequentially rather than simultaneously to minimize cross-talk
Employ deconvolution or super-resolution microscopy for detailed co-localization analysis
Quantify co-localization using Pearson's or Mander's coefficients rather than relying on visual assessment alone
OR10D4P belongs to a large family of olfactory receptors with sequence similarities. To address cross-reactivity concerns:
Perform sequence alignment analysis to identify olfactory receptors with highest homology to OR10D4P
Test antibody reactivity in cell systems overexpressing related olfactory receptors
Implement competitive binding assays with recombinant related receptors
Consider using complementary detection methods (e.g., mRNA detection via qPCR or in situ hybridization)
When possible, validate findings with a second antibody targeting a different epitope within OR10D4P
For comprehensive studies connecting OR10D4P expression with functional outcomes:
Combine antibody-based detection with calcium imaging to correlate receptor expression with odor responses
Use antibody-mediated receptor blocking in functional assays to establish causality
Implement proximity ligation assays to study OR10D4P interactions with downstream signaling components
Compare antibody labeling patterns with functional mapping of olfactory responses
Design experiments that correlate changes in OR10D4P expression levels (detected by antibodies) with alterations in olfactory function
When designing experiments to study OR10D4P expression:
Consider employing true experimental designs with appropriate controls when manipulating expression
For developmental or comparative studies, implement quasi-experimental designs with carefully matched samples
Include time-course analyses to capture dynamic changes in receptor expression
When studying potential regulation, design factorial experiments examining multiple variables simultaneously
For human tissue studies, implement case-control designs with matched samples
To enhance internal validity when using OR10D4P antibodies:
Implement randomization in sample processing and analysis to minimize bias
Blind observers to experimental conditions during quantification
Standardize all experimental protocols including sample preparation, antibody concentrations, and incubation times
Process experimental and control groups in parallel under identical conditions
Include technical replicates to assess method reliability and biological replicates to capture natural variation
Apply appropriate statistical analyses based on experimental design and data distribution
For rigorous quantification of OR10D4P expression:
Use digital image analysis software (ImageJ, Image Studio, etc.) for densitometry
Normalize OR10D4P band intensity to appropriate loading controls (β-actin, GAPDH, etc.)
Ensure analysis remains within the linear range of detection
Include standard curves using recombinant protein when absolute quantification is required
Present data as fold-change relative to control conditions rather than arbitrary units
Apply appropriate statistical tests based on experimental design and data distribution
When facing contradictory results between different detection methods:
Systematically evaluate each method's limitations and strengths:
Western blot: Good for quantification but may detect denatured epitopes only
Immunofluorescence: Provides spatial information but may suffer from fixation artifacts
ELISA: Highly quantitative but lacks spatial information
Confirm antibody specificity under the specific conditions of each method
Consider potential post-translational modifications that might affect epitope recognition
Implement complementary detection methods (mRNA analysis, mass spectrometry)
Examine the literature for similar discrepancies and their resolutions
Design experiments specifically to address the contradictions
For tissue microarray applications with OR10D4P antibodies:
Optimize antigen retrieval methods specifically for fixed tissue sections
Determine optimal antibody concentration through titration experiments
Include positive control tissues (olfactory epithelium) and negative control tissues
Implement standardized scoring systems for immunoreactivity
Consider multiplex immunohistochemistry to examine co-expression with other markers
Validate findings with orthogonal methods when possible
For investigating potential ectopic OR10D4P expression:
Start with sensitive detection methods (immunoprecipitation followed by Western blot)
Confirm specificity through multiple controls including peptide competition
Validate unexpected findings with mRNA detection methods
Consider potential cross-reactivity with related proteins in non-olfactory tissues
Implement functional studies to determine the biological significance of ectopic expression
Examine regulation mechanisms that might explain expression outside the olfactory system